Beginner Guide
Peptides are short chains of amino acids — the same building blocks that make up proteins. The defining characteristic is size: peptides generally contain fewer than 50 amino acids, while proteins contain more. Many of the body's most important signaling molecules are peptides, including insulin, glucagon, oxytocin, and the GLP-1 class of incretin hormones that have become the basis for the most commercially successful class of pharmaceutical drugs in modern history.
Synthetic peptides are laboratory-manufactured versions of these naturally occurring signaling molecules, or novel sequences designed to interact with specific biological receptors. The ability to synthesize precise peptide sequences has opened an enormous research space for studying cellular signaling, metabolic pathways, tissue repair, and aging biology.
Research peptides are sold under a "Research Use Only" (RUO) designation, which means they are intended strictly for in vitro (cell culture) and preclinical laboratory research — not for human or animal consumption. RUO is a legal classification that governs how these compounds can be sold and used. Vendors selling RUO peptides are not permitted to make therapeutic claims, and buyers are confirming research intent at the point of purchase.
This is distinct from pharmaceutical-grade peptides, which have completed FDA clinical trial requirements for specific therapeutic indications. Compounds like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are FDA-approved pharmaceuticals — they have established safety and efficacy data from large-scale human trials and are dispensed by prescription. Research peptides like BPC-157, Retatrutide, and CJC-1295 No DAC are not FDA-approved for therapeutic use and are sold exclusively for laboratory study.
Most research peptides are synthesized using Solid Phase Peptide Synthesis (SPPS) — a process in which amino acids are sequentially added to a growing chain attached to a solid resin support. The finished peptide is cleaved from the resin, purified using High Performance Liquid Chromatography (HPLC), and verified for identity using mass spectrometry. The result is a lyophilized (freeze-dried) powder that is stable at room temperature for shipping and requires reconstitution with bacteriostatic water for laboratory use.
HPLC purity refers to the percentage of the compound that is the target peptide versus impurities — incomplete synthesis fragments, reagent residues, or degradation products. A purity of ≥98% is considered the minimum standard for research-grade material. Lower purity introduces variables that compromise experimental reproducibility. For researchers, sourcing from vendors who provide HPLC purity data — not just a blanket purity claim — is a fundamental quality control practice.
The research peptide market has expanded rapidly, and quality varies significantly across vendors. The minimum standards for a credible research supplier are: independent third-party COA documentation (not self-issued), HPLC purity data, mass spectrometry identity confirmation, and transparent sourcing practices. Plato Peptides provides all of these with every order — every compound ships with a digital COA from an independent ISO-certified laboratory, with purity verified per lot at ≥98% HPLC for most compounds and ≥99% for select high-purity formulations.